Radiotherapy for high-risk prostate cancer
Author:
Publisher
Springer Science and Business Media LLC
Subject
Urology
Link
http://www.nature.com/articles/nrurol.2015.25.pdf
Reference87 articles.
1. Mohler, J. L. et al. Prostate cancer, version 2.2014. J. Natl Compr. Canc. Netw. 12, 686–718 (2014).
2. Widmark, A. et al. Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial. Lancet 373, 301–308 (2009).
3. Warde, P. et al. Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial. Lancet 378, 2104–2111 (2011).
4. Studer, U. E. et al. Immediate or deferred androgen deprivation for patients with prostate cancer not suitable for local treatment with curative intent: European Organisation for Research and Treatment of Cancer (EORTC) Trial 30891. J. Clin. Oncol. 24, 1868–1876 (2006).
5. Lu-Yao, G. L. et al. Survival following primary androgen deprivation therapy among men with localized prostate cancer. JAMA 300, 173–181 (2008).
Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Changes in the gut microbial profile during long-term androgen deprivation therapy for prostate cancer;Prostate Cancer and Prostatic Diseases;2023-09-11
2. RNA m6A modification in prostate cancer: A new weapon for its diagnosis and therapy;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2023-09
3. Efficacy and Toxicity of Whole Pelvic Radiotherapy Versus Prostate-Only Radiotherapy in Localized Prostate Cancer: A Systematic Review and Meta-Analysis;Frontiers in Oncology;2022-01-27
4. A phase I/II study of acute and late physician assessed and patient-reported morbidity following whole pelvic radiation in high-risk prostate cancer patients;Acta Oncologica;2021-09-20
5. Androgen Deprivation Therapy Combined With Particle Therapy for Prostate Cancer: A Systematic Review;Frontiers in Oncology;2021-06-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3